The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - CytRx Corporation
Leadership - CytRx Corporation
Stock and Other Ownership Interests - CytRx Corporation
Phase 2 study of aldoxorubicin in relapsed glioblastoma.
 
Morris D. Groves
Employment - Texas Oncology
Stock and Other Ownership Interests - Agios; Biogen; Epizyme; Galectin Therapeutics; Gilead Sciences; illumina; Karyopharm Therapeutics; Ocata Therapeutics; Pharmacyclics; Synageva Biopharma; Synta; Teva; Valeant Pharmaceuticals International
Honoraria - CytRx Corporation; Foundation Medicine
Consulting or Advisory Role - CytRx Corporation; Foundation Medicine; Incyte; Novocure
Speakers' Bureau - Foundation Medicine; Novocure
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - CytRx Corporation; Foundation Medicine
 
Jana Portnow
Honoraria - CytRx Corporation
Research Funding - Celldex (Inst); CytRx Corporation (Inst); Eisai (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst)
 
Brian C. Boulmay
No Relationships to Disclose
 
Sant P. Chawla
Research Funding - CytRx Corporation (Inst)
 
Hillary Dinh
Employment - CytRx Corporation
 
Shanta Chawla
Employment - CytRx Corporation
Leadership - CytRx Corporation
 
Scott Wieland
Employment - CytRx Corporation
Leadership - CytRx Corporation
Stock and Other Ownership Interests - CytRx Corporation
 
Daniel J. Levitt
No Relationships to Disclose